FIRST LINE MEDICAL COMMUNICATIONS LTD.Active

Company number 03010597Private limited companyIncorporated 1995

Key figures

−£1,856+37.1%
Net assets 2024/25
-3 k-2 k-1 k01 k2019/202020/212021/222023/242024/25

Like most small UK companies, FIRST LINE MEDICAL COMMUNICATIONS LTD. does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 k10 k15 k2019/202020/212021/222023/242024/25
Filed accounts2019/20–2024/25
2019/202020/212021/222023/242024/25
Cash at bank and in hand——12339
Total assets——13,6102,673936
Total liabilities—————
Net assets / total equity380331710-2,953-1,856
Average number of employees22222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: FIRST LINE MEDICAL COMMUNICATIONS LTD.

Company

FIRST LINE MEDICAL COMMUNICATIONS LTD. is a private limited company registered with Companies House under company number 03010597. It was incorporated on 17 Jan 1995. Its status is active. The registered office is in Buckinghamshire (SL7). Its nature of business (SIC 2007) is other software publishing (58290), public relations and communications activities (70210), other professional, scientific and technical activities n.e.c. (74909), other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files small company accounts (filleted). Net assets were −£1,856, up 37.1% on the previous year. Cash at bank and in hand was £39. The company had an average of 2 employees. Figures are available for 5 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 26 Jan 2027.